INPP4B is an oncogenic regulator in human colon cancer

- Guo, S. T., Chi, M. N., Yan, X. G., Farrelly, M., Wang, F. H., Lai, F., Wang, J. F., Li, Y. P., Ackland, S., Scott, R., Agoulnik, I. U., Hondermarck, H., Yang, R. H., Thorne, R. F., Liu, T., Zhang, X. D., Jiang, C. C., Guo, X. Y., Zan, L. K., Wang, C. Y., Xi, Y. F., Jin, L., Croft, A., Tseng, H.-Y.

Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy

- Chi, M., Chen, J., Ye, Y., Tseng, Hsin-Yi, Lai, F., Tay, K. H., Jin, L., Guo, S. T., Jiang, C. C., Zhang, X. D.

Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3

- Lai, F., Guo, S. T., Norman, J., Liu, T., Hersey, P., Zhang, X. D., Jin, L., Jiang, C. C., Wang, C. Y., Croft, A., Chi, M. N., Tseng, H-Y., Farrelly, M., Atmadibrata, B.

Targeting anti-apoptotic mechanisms for reversal of resistance to BRAF inhibitors in melanoma

- Hersey, P., Wroblewski, D., Lai, F., Jiang, C. C., Zhang, X. D.

Apoptosis of human melanoma cells induced by inhibition of B-RAFᵛ⁶⁰⁰ᴱ involves preferential splicing of bimS

- Jiang, C. C., Lai, F., Zhang, X. D., Tay, K. H., Croft, A., Rizos, H., Becker, T. M., Yang, F., Liu, H., Thorne, R. F., Hersey, P.